PARHELIA BIOSCIENCES CORPORATION

PARHELIA BIOSCIENCES CORPORATION specializes in advanced bioscience research and development, with core capabilities centered on the design, testing, and production of specialized biological instruments and diagnostic systems. Leveraging expertise in precision instrumentation and life science engineering, the company focuses on developing laboratory-grade devices compliant with regulatory standards for biological analysis, including sample handling, molecular detection, and data acquisition systems. Their technical proficiency spans microfluidics, sensor integration, and automated assay platforms, with a strong emphasis on reproducibility and analytical accuracy in controlled environments. While specific contract details are not available, their NAICS classification of 334516 indicates a focus on instrumentation for medical and scientific use, suggesting specialization in custom or high-precision bioscience equipment rather than mass-market consumer products. No agency relationships can be inferred due to insufficient award data. The company’s market positioning is aligned with federal and state research entities requiring specialized bioscience instrumentation, though no confirmed partnerships with specific departments are documented. The primary NAICS code 334516 corresponds to the manufacturing of medical and laboratory instruments, indicating a vertical specialization in analytical and diagnostic equipment used in research, clinical, and public health settings. This positions PARHELIA as a niche supplier of technical systems requiring stringent quality control and regulatory alignment. The company is structured as a small business (2L entity) based in Ashland, Oregon, with no public certifications on record. Its geographic presence is localized, suggesting a focused operational footprint centered on specialized R&D and low-volume, high-complexity manufacturing. Without certified status or visible federal contract history, the firm appears to operate as an emerging supplier within the scientific instrumentation sector, potentially seeking to expand its footprint through targeted federal opportunities.